Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selinexor in Advanced Liposarcoma (SEAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02606461
Recruitment Status : Active, not recruiting
First Posted : November 17, 2015
Last Update Posted : May 5, 2021
Sponsor:
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 2020
Estimated Study Completion Date : December 2021